Fundraising FoxJacobiopharma
Beijing, CN · 3 known investors
Find your way into Jacobiopharma
Sign up to find every way you can get introduced to Jacobiopharma
- Your email: who you already know at Jacobiopharma, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Jacobiopharma team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Jacobio is a biopharmaceutical company developing novel oncology therapeutics, focusing on next-generation antibody-conjugated drugs including ATDCs, ISACs, and AOCs to treat cancer patients.
Founders & leadership
WY
Wang YinxiangChairman and Co-Chief Executive Officer
WY
Wang YiCo-Chief Executive Officer, Chief Medical Officer
Investors · 3
Lilly Asia Ventureslisted by Lilly Asia VenturesHong Kongvia Hongbo Lu · inferred
How we know: the VCSheet dataset · Not right? Tell us
Qiming Venture Partnerslisted by Qiming Venture PartnersBeijing · $5M – $134M
How we know: Qiming Venture Partners's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Jacobiopharma do?
- Jacobio is a biopharmaceutical company developing novel oncology therapeutics, focusing on next-generation antibody-conjugated drugs including ATDCs, ISACs, and AOCs to treat cancer patients.
- Who founded Jacobiopharma?
- Jacobiopharma was founded by Wang Yinxiang.
- Who are Jacobiopharma's investors?
- Jacobiopharma's investors include LAV, Lilly Asia Ventures, Qiming Venture Partners.
- Where is Jacobiopharma headquartered?
- Jacobiopharma is headquartered in Beijing, CN.